WO2006116556A3 - Composition comprising proton pump inhibitor and buffer - Google Patents

Composition comprising proton pump inhibitor and buffer Download PDF

Info

Publication number
WO2006116556A3
WO2006116556A3 PCT/US2006/015939 US2006015939W WO2006116556A3 WO 2006116556 A3 WO2006116556 A3 WO 2006116556A3 US 2006015939 W US2006015939 W US 2006015939W WO 2006116556 A3 WO2006116556 A3 WO 2006116556A3
Authority
WO
WIPO (PCT)
Prior art keywords
proton pump
pump inhibitor
buffer
composition
compositions
Prior art date
Application number
PCT/US2006/015939
Other languages
French (fr)
Other versions
WO2006116556A2 (en
Inventor
Jeffrey Phillips
Original Assignee
Univ Missouri
Jeffrey Phillips
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Missouri, Jeffrey Phillips filed Critical Univ Missouri
Publication of WO2006116556A2 publication Critical patent/WO2006116556A2/en
Publication of WO2006116556A3 publication Critical patent/WO2006116556A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Abstract

The present invention relates to, inter alia, pharmaceutical compositions comprising an acid labile proton pump inhibitor, a buffering agent, and at least one additional pharmaceutically acceptable excipient. Also provided are methods for manufacture of such compositions, and to use of such compositions in treating and preventing diseases and/or disorders.
PCT/US2006/015939 2005-04-26 2006-04-25 Composition comprising proton pump inhibitor and buffer WO2006116556A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67512205P 2005-04-26 2005-04-26
US60/675,122 2005-04-26

Publications (2)

Publication Number Publication Date
WO2006116556A2 WO2006116556A2 (en) 2006-11-02
WO2006116556A3 true WO2006116556A3 (en) 2007-08-16

Family

ID=37215477

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/015939 WO2006116556A2 (en) 2005-04-26 2006-04-25 Composition comprising proton pump inhibitor and buffer

Country Status (1)

Country Link
WO (1) WO2006116556A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008057802A2 (en) * 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2009105568A1 (en) 2008-02-20 2009-08-27 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054862A1 (en) * 2001-10-09 2005-03-10 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054862A1 (en) * 2001-10-09 2005-03-10 Cyclics Corporation Organo-titanate catalysts for preparing pure macrocyclic oligoesters

Also Published As

Publication number Publication date
WO2006116556A2 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2005117870A3 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
WO2008076392A3 (en) Compounds useful as protein kinase inhibitors
WO2005105780A3 (en) Compositions useful as inhibitors of rock and other protein kinases
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2007135527A3 (en) Benzimidazolyl compounds
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2007066150A3 (en) Transdermal administration of active agents for systemic effect
WO2005076987A3 (en) Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2009109618A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
WO2005067893A3 (en) Pharmaceutical compositions comprising midazolam in a high concentration
WO2006138735A3 (en) Gel compositions for topical administration
WO2006089114A3 (en) Methods and compositions for treating an anthrax toxin mediated condition
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
TW200733961A (en) Diaryl urea for treating pulmonary hypertension
ATE554084T1 (en) N-HYDROXYACRYLAMIDE COMPOUNDS
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2006108682A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents
WO2007133944A3 (en) Topical administration of acyclovir
WO2003066597A3 (en) Guanidino compounds
WO2007123740A3 (en) Pharmaceutical compositions for promoting wound healing
WO2006042478A8 (en) Small-molecule inhibitors of coronaviral main protease, their preparation and use
WO2007087026A3 (en) Solid-state form of amg 706 and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06751582

Country of ref document: EP

Kind code of ref document: A2